HeartSciences Inc. (NASDAQ:HSCS) Short Interest Update

HeartSciences Inc. (NASDAQ:HSCS) was the target of a large growth in short interest in the month of February. As of February 27th, there was short interest totaling 37,981 shares, a growth of 27.6% from the February 12th total of 29,772 shares. Approximately 1.2% of the shares of the company are sold short. Based on an average daily volume of 9,560 shares, the days-to-cover ratio is currently 4.0 days. Based on an average daily volume of 9,560 shares, the days-to-cover ratio is currently 4.0 days. Approximately 1.2% of the shares of the company are sold short.

Analyst Ratings Changes

HSCS has been the subject of several research analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of HeartSciences in a research report on Monday, December 29th. Ascendiant Capital Markets boosted their target price on shares of HeartSciences from $9.00 to $9.20 and gave the company a “buy” rating in a report on Monday, December 22nd. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $9.20.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of HSCS. TFB Advisors LLC acquired a new position in HeartSciences in the third quarter worth $105,000. Geode Capital Management LLC grew its holdings in HeartSciences by 110.7% in the 4th quarter. Geode Capital Management LLC now owns 26,928 shares of the company’s stock worth $83,000 after buying an additional 14,150 shares in the last quarter. Finally, DRW Securities LLC increased its holdings in shares of HeartSciences by 13.7% during the fourth quarter. DRW Securities LLC now owns 95,065 shares of the company’s stock valued at $294,000 after purchasing an additional 11,455 shares during the period. Hedge funds and other institutional investors own 17.24% of the company’s stock.

HeartSciences Price Performance

HeartSciences stock traded up $0.09 during midday trading on Monday, reaching $2.66. The company’s stock had a trading volume of 10,785 shares, compared to its average volume of 9,285. HeartSciences has a fifty-two week low of $2.01 and a fifty-two week high of $6.47. The stock’s 50 day simple moving average is $3.01 and its 200 day simple moving average is $3.06.

HeartSciences (NASDAQ:HSCS) last announced its quarterly earnings results on Monday, December 15th. The company reported ($0.85) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.90) by $0.05. The business had revenue of $2.42 million during the quarter, compared to analysts’ expectations of $0.00 million. As a group, analysts predict that HeartSciences will post -10.01 earnings per share for the current fiscal year.

About HeartSciences

HeartSciences, Inc (NASDAQ: HSCS) is a medical device company focused on the development and commercialization of advanced, non‐invasive cardiac diagnostic technologies. The company’s flagship product, MyoVista, is a high‐fidelity electrocardiograph (ECG) designed to detect subtle changes in cardiac function that may indicate myocardial ischemia or left ventricular dysfunction. By leveraging high‐frequency wavelet analysis within the QRS complex, MyoVista provides clinicians with enhanced visualization and analytical capabilities that extend beyond those of standard ECG systems.

HeartSciences supports the MyoVista system with an integrated software suite that automates data analysis and report generation, facilitating seamless integration into existing clinical workflows.